comparemela.com

Emanuele Zucca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ASCO 2023: Lymphoma Research Could Change Practice

Studies presented at the ASCO Annual Meeting 2023 highlighted new developments in lymphoma that could lead to changes in practice.

United statesDana farber cancer instituteRichardf ambinderEmanuele zuccaAlex herreraReid merrymanOncology institute of southern switzerlandJohns hopkins kimmel cancer centerNivolumab plusOncology instituteSouthern switzerland

PMBCL: Postremission, Patients May Safely Skip Radiation

Radiation therapy may be safely omitted for patients with primary mediastinal B-cell lymphoma (PMBCL) who achieved a complete metabolic response after immunochemotherapy.

United statesUnited kingdomAnn arborJulier gralowCoreyw speersEmanuele zuccaCelgene incyteUniversity of michigan hospitalSwiss national science foundationCancer research united kingdomAmerican society of clinical oncologySwiss cancer leagueOncology institute of southern switzerlandOncology instituteSouthern switzerlandAmerican society

Skipping Radiotherapy Seems Safe for PMBCL Patients in Remission

PET-negative patients after chemoimmunotherapy fared well with observation alone

Fort pierceUnited statesEmanuele zuccaEd susmanCorey speersUniversity hospitals in clevelandAmerican society of clinical oncologyOncology institute of southern switzerlandEastern cooperative oncology groupInternational prognostic indexCase western reserve universityOncology instituteSouthern switzerlandAmerican societyClinical oncologyUniversity hospitals

vimarsana © 2020. All Rights Reserved.